Nasdaq · CIK 0001631487
CLGN CollPlant Biotechnologies Ltd
Insider trading from SEC Form 4. Last filing 35 d ago.
CollPlant Biotechnologies Ltd (CLGN) has 2 SEC Form 4 filings on file from 2 insiders, the latest filed on Sep 8, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
1 Form 144 notice of planned sales is on file, the latest filed Oct 9, 2025.
Last 90 days
Signals
Open-market buys and sells at CollPlant Biotechnologies Ltd, scored.
Planned sales
Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales
| Filed | Seller | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 9, 2025 | Ami Sagy Shareholder | 140,000 1.10% of outstanding | $308k | Oct 10, 2025 | none |
Transactions
Every row filed, 2 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Bar Berta Abelis VP Legal | AGrant or award Ordinary Shares | +201,141 | $0.00 | $0 | 206,441 | 35 d ago |
| Sep 3, 2026 | Eran Rotem Deputy CEO and CFO | AGrant or award Ordinary Shares | +510,372 | $0.00 | $0 | 516,372 | 35 d ago |
Questions about CLGN
Answered from the filings on this page, as of the latest one.
Are insiders buying CLGN?
No. In the last 90 days no insider at CollPlant Biotechnologies Ltd bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade CLGN on the open market?
No open-market trade has been scored at CollPlant Biotechnologies Ltd. The latest Form 4 on file was filed on Sep 8, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at CollPlant Biotechnologies Ltd?
2 people have filed a Form 4 at CollPlant Biotechnologies Ltd, among them Bar Berta Abelis (VP Legal), Eran Rotem (Deputy CEO and CFO). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.